Related Experiment Video
Updated: Oct 23, 2025

08:10
The 6-hydroxydopamine Rat Model of Parkinson's Disease
Published on: October 27, 2021
11.6K
Modeling Parkinson's Disease: Not Only Rodents?
Maria Shadrina1, Petr Slominsky1
1Laboratory of Molecular Genetics of Hereditary Diseases, Institute of Molecular Genetics of National Research Centre "Kurchatov Institute", Moscow, Russia.
Frontiers in Aging Neuroscience
|August 23, 2021
Summary
Parkinson's disease (PD) research explores genetic links and biological pathways. This review examines various animal models, from yeast to mammals, to understand PD
Area of Science:
- Neurodegenerative Diseases
- Genetics
- Pathogenesis
Background:
- Parkinson's disease (PD) is a progressive neurodegenerative disorder with both sporadic and inherited forms.
- Mutations in seven genes (SNCA, LRRK2, VPS35, PRKN, PINK1, GBA, DJ-1) are confirmed causes of familial PD.
- Genetic variability at 90 loci is linked to PD risk, implicating mitochondrial and lysosomal dysfunction, and immune processes.
Purpose of the Study:
- To review and analyze diverse in vivo models for studying Parkinson's disease pathogenesis.
- To explore the utility of various organisms in modeling early-stage PD mechanisms.
- To understand the pathological processes of PD from its earliest stages.
Main Methods:
- Review of studies published since the 2000s focusing on PD models.
- Analysis of toxic rodent models.
- Inclusion of in vivo models using diverse organisms: yeast, nematodes, Drosophila, and mammals.
Main Results:
- Toxic rodent models are predominantly used.
- Diverse organisms offer valuable insights into PD pathogenesis.
- Modeling allows in-depth study of pathological processes from early stages.
Conclusions:
- Various PD models, including non-mammalian organisms, are crucial for understanding disease mechanisms.
- Studying diverse models aids in elucidating the complex pathogenesis of Parkinson's disease.
- Research into early-stage PD is facilitated by comprehensive analysis of these models.
Related Concept Videos
Parkinson's Disease: Overview
981
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
981
EPS and iPS Cells in Disease Research
3.0K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.0K
Parkinson's Disease: Treatment
562
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
562

